Medication and Performance Enhancing Drugs in Horse Racing

Full Committee Hearing
Date:  Thursday, July 12, 2012
Time:  2:00 PM
Location:  Russell Senate Office Building

Feature Image: Capitol 1WASHINGTON, D.C.— The U.S. Senate Committee on Commerce, Science, and Transportation will hold a hearing next week on “Medication and Performance Enhancing Drugs in Horse Racing.” This hearing will examine the prevalence and use of medications and performance enhancing drugs in horse racing.

Please note the hearing will be webcast live via the Senate Commerce Committee website.  Refresh the Commerce Committee homepage 10 minutes prior to the scheduled start time to automatically begin streaming the webcast.

Individuals with disabilities who require an auxiliary aid or service, including closed captioning service for webcast hearings, should contact Collenne Wider at 202-224-5511 at least three business days in advance of the hearing date.

###

Committee Members

  • John Rockefeller

    Chairman
  • Tom Udall

Testimony

  • Barry Irwin

    Chief Executive Officer
    Team Valor International
  • Kent Stirling

    Executive Director, Florida Horsemen’s Benevolent & Protective Association
    Chairman, Medication Committee, National Horsemen’s Benevolent & Protective Association
  • Jeffrey Gural

    Chairman, Newmark Grubb Knight Frank
    Chairman and Managing Partner, American Racing and Entertainment, LLC
  • Jim Gagliano

    President
    The Jockey Club

Witness Panel 2

  • Matthew Witman

    National Director
    American Quarter Horse Association
  • Marc Paulhus

    Former Director of Equine Protection and Vice President
    Humane Society
  • Ed Martin

    President and CEO
    Association of Racing Commissioners International
  • Sheila Lyons

    Founder and Director, The American College of Veterinary Sports Medicine and Rehabilitation
    Founder and Director, Homecoming Farm, Inc.
Print 
Email 
Share 
Share